These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30245959)

  • 1. Human carboxylesterases: a comprehensive review.
    Wang D; Zou L; Jin Q; Hou J; Ge G; Yang L
    Acta Pharm Sin B; 2018 Sep; 8(5):699-712. PubMed ID: 30245959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxylesterase Inhibitors: An Update.
    Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L
    Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in the discovery of natural inhibitors against human carboxylesterases.
    Wang DD; Zou LW; Jin Q; Hou J; Ge GB; Yang L
    Fitoterapia; 2017 Mar; 117():84-95. PubMed ID: 28126414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxylesterases: Dual roles in lipid and pesticide metabolism.
    Ross MK; Streit TM; Herring KL
    J Pestic Sci; 2010; 35(3):257-264. PubMed ID: 25018661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
    Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
    Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor.
    Holmes RS; Chan J; Cox LA; Murphy WJ; VandeBerg JL
    BMC Evol Biol; 2008 Feb; 8():54. PubMed ID: 18289373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics.
    Di L
    Curr Drug Metab; 2019; 20(2):91-102. PubMed ID: 30129408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review.
    Liu Y; Li J; Zhu HJ
    Expert Opin Drug Metab Toxicol; 2024 May; 20(5):377-397. PubMed ID: 38706437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human.
    Williams ET; Bacon JA; Bender DM; Lowinger JJ; Guo WK; Ehsani ME; Wang X; Wang H; Qian YW; Ruterbories KJ; Wrighton SA; Perkins EJ
    Drug Metab Dispos; 2011 Dec; 39(12):2305-13. PubMed ID: 21918037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.
    Crow JA; Herring KL; Xie S; Borazjani A; Potter PM; Ross MK
    Biochim Biophys Acta; 2010 Jan; 1801(1):31-41. PubMed ID: 19761868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horse carboxylesterases: evidence for six CES1 and four families of CES genes on chromosome 3.
    Holmes RS; Cox LA; Vandeberg JL
    Comp Biochem Physiol Part D Genomics Proteomics; 2009 Mar; 4(1):54-65. PubMed ID: 20403742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs.
    Liu D; Gao J; Zhang C; Ren X; Liu Y; Xu Y
    Pharmazie; 2011 Nov; 66(11):888-93. PubMed ID: 22204136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability.
    Yerrakula G; Abraham S; John S; Zeharvi M; George SG; Senthil V; Maiz F; Rahman MH
    Biotechnol Genet Eng Rev; 2024 Dec; 40(4):3174-3192. PubMed ID: 35946821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
    Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
    Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases.
    Liu YZ; Pan LH; Bai Y; Yang K; Dong PP; Fang ZZ
    Environ Pollut; 2020 Aug; 263(Pt A):114463. PubMed ID: 32283456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs.
    Hosokawa M
    Molecules; 2008 Feb; 13(2):412-31. PubMed ID: 18305428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of carboxylesterases 1 and 2 plays an important role in prodrug metabolism in immunological liver injury rats.
    Zhang C; Xu Y; Gao P; Lu J; Li X; Liu D
    Int Immunopharmacol; 2015 Feb; 24(2):153-158. PubMed ID: 25499727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Caco-2 Cell Line Carrying the Human Intestine-Type CES Expression Profile as a Promising Tool for Ester-Containing Drug Permeability Studies.
    Ishizaki Y; Furihata T; Oyama Y; Ohura K; Imai T; Hosokawa M; Akita H; Chiba K
    Biol Pharm Bull; 2018; 41(5):697-706. PubMed ID: 29709907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
    Merali Z; Ross S; Paré G
    Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2?
    Xu J; Qiu JC; Ji X; Guo HL; Wang X; Zhang B; Wang T; Chen F
    Curr Drug Metab; 2019; 20(2):130-137. PubMed ID: 29600756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.